Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15208704 | 0.98 | ANPEP (0.41) | ANPEPERAP2 | |
| SCHEMBL15208602 | 0.98 | ANPEP (0.41) | ANPEPERAP2 | |
| SCHEMBL12249043 | 0.89 | ALDH1A1 (0.30) | — | |
| SCHEMBL12249051 | 0.89 | ALDH1A1 (0.30) | — | |
| SCHEMBL15338640 | 0.89 | — | — | |
| SCHEMBL1273926 | 0.89 | — | — | |
| SCHEMBL8343443 | 0.88 | ANPEP (0.40) | ANPEPERAP2OPRM1 | |
| SCHEMBL12249027 | 0.86 | — | — | |
| SCHEMBL12248119 | 0.86 | — | — | |
| SCHEMBL338761 | 0.84 | ANPEP (0.49) | ANPEPERAP2OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2638003-B1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-11-20 | — | — | EP | disclosed |
| US-9000217-B2 | Transamination of nitrogen-containing compounds to high molecular weight polyalkyleneamines | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-04-07 | — | — | US | disclosed |
| US-20130225864-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | DOW GLOBAL TECHNOLOGIES LLC | 2013-08-29 | — | — | US | disclosed |
| US-5914072-A | DISPERSANTS FOR SOLIDS; FOR USE IN PAINTS, INKS | BASF AKTIENGESELLSCHAFT (DE) | 1999-06-22 | — | — | US | disclosed |
| EP-0759440-A2 | Phosphoric acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1997-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225864-A1 | TRANSAMINATION OF NITROGEN-CONTAINING COMPOUNDS TO HIGH MOLECULAR WEIGHT POLYALKYLENEAMINES | PARG, PNMT, HNMT | ANPEP 410/4885ERAP2 3545/4885OPRM1 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.